Barclays PLC Genmab A/S Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Genmab A/S stock. As of the latest transaction made, Barclays PLC holds 213 shares of GMAB stock, worth $4,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213

Previous 5 4160.0%

Holding current value

$4,385

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$23.84 - $28.48 $4,958 - $5,923	208 Added 4160.0%	213 $5,000
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $1.53 Million - $1.85 Million	-61,000 Reduced 99.99%	5 $0
Q1 2024 May 15, 2024	BUY	$26.43 - $32.77 $1.61 Million - $2 Million	61,000 Added 1220000.0%	61,005 $1.83 Million
Q4 2023 Feb 15, 2024	SELL	$27.94 - $35.44 $139 - $177	-5 Reduced 50.0%	5 $0
Q2 2023 Aug 03, 2023	BUY	$37.4 - $42.94 $187 - $214	5 Added 100.0%	10 $0
Q1 2023 May 04, 2023	SELL	$34.88 - $43.22 $1.36 Million - $1.69 Million	-39,100 Reduced 99.99%	5 $0
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $3,379 - $4,706	100 Added 0.26%	39,105 $1.66 Million
Q3 2022 Nov 03, 2022	BUY	$31.52 - $373.61 $1.23 Million - $14.6 Million	39,000 Added 780000.0%	39,005 $1.25 Million
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $1,234 - $1,774	-46 Reduced 90.2%	5 $0
Q1 2022 May 16, 2022	BUY	$30.95 - $39.68 $1,578 - $2,023	51 New	51 $2,000
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $346,145 - $454,708	-9,650 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$41.55 - $48.72 $2,409 - $2,825	58 Added 0.6%	9,650 $422,000
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $307,066 - $416,239	9,339 Added 3691.3%	9,592 $392,000
Q1 2021 May 13, 2021	BUY	$30.92 - $44.4 $6,400 - $9,190	207 Added 450.0%	253 $8,000
Q2 2020 Aug 12, 2020	BUY	$20.05 - $33.89 $922 - $1,558	46 New	46 $2,000
Q1 2020 May 13, 2020	SELL	$17.15 - $25.22 $2,075 - $3,051	-121 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$18.88 - $24.14 $76,690 - $98,056	-4,062 Reduced 97.11%	121 $3,000
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $75,294 - $89,432	4,183 New	4,183 $84,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account